Royalty Pharma PLC (FRA:RPD)
€ 25.01 0.21 (0.85%) Market Cap: 11.19 Bil Enterprise Value: 16.72 Bil PE Ratio: 10.43 PB Ratio: 1.73 GF Score: 76/100

Royalty Pharma plc MorphoSys Transaction Conference Call Transcript

Jun 02, 2021 / 12:45PM GMT
Release Date Price: €34.4 (+5.52%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to Royalty Pharma's conference call on the MorphoSys transaction. I would now like to turn the call over to George Grofik, SVP, Head of Investor Relations and Communications. Please go ahead, sir.

George Grofik
RP Management LLC - Senior VP and Head of IR & Communications

Good morning and good afternoon to everyone on the call. Thank you for joining us to review Royalty Pharma's transaction with MorphoSys. You can find the slides for this call on the Investors page of our website at royaltypharma.com.

Moving to Slide 3, I'd like to remind you that information presented in this call contains forward-looking statements that involve known and unknown risks, uncertainties and other factors may cause actual results to differ materially. I refer you to our 10-K on file with the SEC for a discussion of these risks.

And with that, please advance to Slide 4. Our speakers on the call today are Pablo Legorreta Founder and Chief Executive Officer; Chris Hite, EVP, Vice Chairman; Marshall Urist

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot